Small bowel angioectasia as a marker of frailty and poor prognosis

Abstract

Background and study aims This study aimed to establish 5-year survival of patients diagnosed with bleeding small bowel (SB) angioectasia, with the hypothesis that many will suffer deaths relating to comorbidity rather than gastrointestinaI bleeding.

Patients and methods SB capsule endoscopy (SBCE) procedures, performed for suspected SB bleeding or iron deficiency anemia, with angioectasia isolated as the cause of SB bleeding and at least 5 years of follow-up data were isolated (n = 125) along with an age-matched group with “normal” SBCE procedures (n = 125). These were retrospectively analysed with further information on mortality and comorbidity gathered through hospital records.

Results Those with angioectasia had a median age of 72.7 years and comorbidities were common. The 5-year survival was 64.0 % (80/125) compared to 70.4 % (88/125) in those with “normal” SBCE. Those with significant cardiac or vascular comorbidity had a poorer survival (52.9 % (37/70) at 5 years) but anticoagulation/antiplatelets/ number of lesions or requirement endoscopic treatment seemed to make little difference. In those with SB bleeding secondary to angioectasia none of the subsequent deaths were directly attributable to gastrointestinal bleeding.

Conclusions In this cohort, SB angioectasia did not lead to any deaths but the 5-year survival was poor due to those diagnosed often being older and having comorbidities. This would support the hypothesis that a diagnosis of SB bleeding secondary to angioectasia suggests frailty.

Publication History

Received: 08 October 2019

Accepted: 12 February 2020

Article published online:
30 June 2020

• References

• 1 Liao Z, Gao R, Xu C. et al. Indications and detection, completion, and retention rates of small-bowel capsule endoscopy: a systematic review. Gastrointest Endosc 2010; 72: 280-286
• 2 Warkentin TE, Moore JC, Anand SS. et al. Gastrointestinal bleeding, angiodysplasia, cardiovascular disease, and acquired von Willebrand Syndrome. Transfus Med Rev 2003; 17: 272-286
• 3 Regula J, Wronska E, Pachlewski J. Vascular lesions of the gastrointestinal tract. Best Pract Res Clin Gastroenterol 2008; 22: 313-328
• 4 Sucker C, Michiels JJ, Zotz RB. Causes, etiology and diagnosis of acquired von willebrand disease: A prospective diagnostic workup to establish the most effective therapeutic strategies. Acta Haematol 2009; 121: 177-182
• 5 Lutz J, Menke J, Sollinger D. et al. Haemostasis in chronic kidney disease. Nephrol. Dial Transplant 2014; 29: 29-40
• 6 Kaw D, Malhotra D. Platelet dysfunction and end-stage renal disease. Semin. Dial. 19. Malden, USA: Blackwell Publishing Inc.; 2006: 317-322
• 7 Noone AM, Howlader N, Krapcho M. et al. Cancer Statistics Review, 1975–2015 – SEER Statistics. SEER Cancer Stat. Rev; 2017
• 8 Arai M, Matsumura T, Ohta Y. et al. Long-term prognosis of patients with obscure gastrointestinal bleeding: a retrospective cohort study. Digestion 2019; 100: 37-44
• 9 National Records of Scotland. Life Expectancy in Scottish Areas, 2015–2017. A National Statistics publication for Scotland. 2018
• 10 Gaskell H, Derry S, Moore AR. et al. Prevalence of anaemia in older persons: Systematic review. BMC Geriatr 2008; 8: 1